1-7 of 7
Eliza A. Hawkes
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

PET/CT-derived coronary calcium score may predict cardiac complications in anthracycline-treated lymphoma patients

Genevieve Douglas, Zoe Loh, Evonne Sai Yeng Shum, Sze-Ting Lee, Niamh Waters, Garry Hamilton, Geoffrey Chong, Alexandra Murphy, Eliza A. Hawkes
Journal: Blood Advances
Blood Adv bloodadvances.2024013620.
https://doi.org/10.1182/bloodadvances.2024013620
Published: 2024
Includes: Supplemental data
Journal Articles

Ibrutinib plus rituximab and mini-CHOP in older patients with newly diagnosed DLBCL: a phase 2 ALLG study

Clinical Trials & Observations
Emma Verner, Amanda Johnston, Nalini Pati, Eliza A. Hawkes, Hui-Peng Lee, Tara Cochrane, Chan Yoon Cheah, Robin Filshie, Duncan Purtill, Hanlon Sia, Anoop K. Enjeti, Christina Brown, Nicholas Murphy, Jennifer Curnow, Kenneth Lee, Maher K. Gandhi, Mannu Walia, Belinda E. Butcher, Judith Trotman
Journal: Blood Advances
Blood Adv (2024) 8 (21): 5674–5682.
https://doi.org/10.1182/bloodadvances.2024014035
Published: 2024
Includes: Supplemental data
Journal Articles

Infections in patients with lymphoma treated with bispecific antibodies: a systematic review and meta-analysis

Clinical Trials & Observations
Gemma K. Reynolds, Marsali Maclean, Edward R. Scheffer Cliff, Benjamin W. Teh, Karin A. Thursky, Monica A. Slavin, Mary Ann Anderson, Eliza A. Hawkes
Journal: Blood Advances
Blood Adv (2024) 8 (13): 3555–3559.
https://doi.org/10.1182/bloodadvances.2024012916
Published: 2024
Includes: Supplemental data
Journal Articles

Utility of FDG-PET in predicting the histology of relapsed or refractory lymphoma

Shin Hnin Wai, Sze Ting Lee, Edward R. Scheffer Cliff, Michael Bei, Jiwoo Lee, Eliza A. Hawkes, Geoffrey Chong
Journal: Blood Advances
Blood Adv (2024) 8 (3): 736–745.
https://doi.org/10.1182/bloodadvances.2023011566
Published: 2024
Includes: Supplemental data
Journal Articles

Safety and efficacy of zanubrutinib in relapsed/refractory marginal zone lymphoma: final analysis of the MAGNOLIA study

Clinical Trials & Observations
Stephen Opat, Alessandra Tedeschi, Bei Hu, Kim M. Linton, Pamela McKay, Sophie Leitch, Morton Coleman, Pier Luigi Zinzani, Jie Jin, Mingyuan Sun, Magdalena Sobieraj-Teague, Peter Browett, Xiaoyan Ke, Catherine Thieblemont, Kirit Ardeshna, Fontanet Bijou, Patricia Walker, Eliza A. Hawkes, Shir-Jing Ho, Keshu Zhou, Zhiyu Liang, Jianfeng Xu, Chris Tankersley, Richard Delarue, Melannie Co, Judith Trotman
Journal: Blood Advances
Blood Adv (2023) 7 (22): 6801–6811.
https://doi.org/10.1182/bloodadvances.2023010668
Published: 2023
Includes: Supplemental data
Journal Articles

Molecular associations of response to the new-generation BTK inhibitor zanubrutinib in marginal zone lymphoma

Clinical Trials & Observations
Maciej Tatarczuch, Mark Waltham, Jake Shortt, Galina Polekhina, Eliza A. Hawkes, Shir-Jing Ho, Judith Trotman, Daniella Brasacchio, Melannie Co, Jessica Li, Vanitha Ramakrishnan, Karin Dunne, Stephen S. Opat, Gareth P. Gregory
Journal: Blood Advances
Blood Adv (2023) 7 (14): 3531–3539.
https://doi.org/10.1182/bloodadvances.2022009412
Published: 2023
Includes: Supplemental data
Journal Articles

Safety and efficacy of atezolizumab with rituximab and CHOP in previously untreated diffuse large B-cell lymphoma

Clinical Trials & Observations
Anas Younes, John M. Burke, Bruce D. Cheson, Catherine S. Diefenbach, Silvia Ferrari, Uwe H. Hahn, Eliza A. Hawkes, Cyrus Khan, Izidore S. Lossos, Gerardo Musuraca, Monica Tani, Umberto Vitolo, Sam Yuen, Aparna Raval, Mahesh Shivhare, Tina G. Nielsen, Gila Sellam, Jeff P. Sharman
Journal: Blood Advances
Blood Adv (2023) 7 (8): 1488–1495.
https://doi.org/10.1182/bloodadvances.2022008344
Published: 2023
Includes: Supplemental data